TickerFacts.

A business in context

CHRS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-28 · 0001104659-26-103316 · Items 8.01,9.01

  2. 8-K · Current report

    Report date 2026-08-17 · 0001104659-26-097951 · Items 7.01,8.01,9.01

  3. 8-K · Current report

    Report date 2026-08-17 · 0001104659-26-097949 · Items 1.01,1.02,2.03,9.01

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-091262

  5. 8-K · Current report

    Report date 2026-08-05 · 0001104659-26-091188 · Items 2.02,9.01

  6. 8-K · Current report

    Report date 2026-06-12 · 0001104659-26-074090 · Items 4.01,9.01

  7. 4 · Ownership change

    Report date 2026-06-05 · 0001610717-26-000206

  8. 4 · Ownership change

    Report date 2026-06-05 · 0001610717-26-000205

  9. 4 · Ownership change

    Report date 2026-06-05 · 0001610717-26-000204

  10. 4 · Ownership change

    Report date 2026-06-05 · 0001610717-26-000203

  11. 4 · Ownership change

    Report date 2026-06-05 · 0001610717-26-000202

  12. 4 · Ownership change

    Report date 2026-06-05 · 0001610717-26-000201

  13. 4 · Ownership change

    Report date 2026-06-05 · 0001610717-26-000200

  14. 4 · Ownership change

    Report date 2026-05-29 · 0001104659-26-069622

  15. 8-K · Current report

    Report date 2026-05-27 · 0001104659-26-068615 · Items 5.07

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-058703

  17. 8-K · Current report

    Report date 2026-05-11 · 0001104659-26-058666 · Items 2.02,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-05-27 · 0001104659-26-045251

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-025308

  20. 8-K · Current report

    Report date 2026-03-09 · 0001104659-26-025293 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-02-12 · 0001104659-26-016378 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2026-02-04 · 0001104659-26-010065 · Items 8.01

  23. 8-K · Current report

    Report date 2026-01-23 · 0001104659-26-006307 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2026-01-13 · 0001104659-26-003117 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-11-13 · 0001104659-25-111484 · Items 8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-107852

  27. 8-K · Current report

    Report date 2025-11-06 · 0001104659-25-107780 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-09-05 · 0001558370-25-011911 · Items 8.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-010803

  30. 8-K · Current report

    Report date 2025-08-07 · 0001558370-25-010802 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-06-30 · 0001558370-25-009085 · Items 3.01

  32. 8-K · Current report

    Report date 2025-06-11 · 0001104659-25-059351 · Items 5.07

  33. 8-K · Current report

    Report date 2025-05-29 · 0001558370-25-008294 · Items 5.03,7.01,9.01

  34. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-007418

  35. 8-K · Current report

    Report date 2025-05-12 · 0001558370-25-007410 · Items 2.02,9.01

  36. DEF 14A · Proxy statement

    Report date 2025-06-11 · 0001558370-25-005825

  37. 8-K · Current report

    Report date 2025-04-22 · 0001558370-25-005554 · Items 5.02

  38. 8-K · Current report

    Report date 2025-04-16 · 0001558370-25-005157 · Items 5.02

  39. 8-K · Current report

    Report date 2025-04-11 · 0001558370-25-004746 · Items 2.01,7.01,9.01

  40. 8-K · Current report

    Report date 2025-03-31 · 0001558370-25-004264 · Items 1.01,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 29 transaction rows29AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

44 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-05
2026-06-09
Satvat Ali J.A · Grant / award
Acquired
Common Stock30000.00.0
2026-06-05
2026-06-09
Satvat Ali J.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
60000.00.0
2026-06-05
2026-06-09
Karachun Rita AA · Grant / award
Acquired
Common Stock30000.00.0
2026-06-05
2026-06-09
Karachun Rita AA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
60000.00.0
2026-06-05
2026-06-09
Newcomer Lee NisleyA · Grant / award
Acquired
Common Stock30000.00.0
2026-06-05
2026-06-09
Newcomer Lee NisleyA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
60000.00.0
2026-06-05
2026-06-09
Ryan Michael LeeA · Grant / award
Acquired
Common Stock30000.00.0
2026-06-05
2026-06-09
Ryan Michael LeeA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
60000.00.0
2026-06-05
2026-06-09
O'Donnell-Tormey JillA · Grant / award
Acquired
Common Stock30000.00.0
2026-06-05
2026-06-09
O'Donnell-Tormey JillA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
60000.00.0
2026-06-05
2026-06-09
Wahlstrom MatsA · Grant / award
Acquired
Common Stock30000.00.0
2026-06-05
2026-06-09
Wahlstrom MatsA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
60000.00.0
2026-06-05
2026-06-09
Newton Charles W.A · Grant / award
Acquired
Common Stock30000.00.0
2026-06-05
2026-06-09
Newton Charles W.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
60000.00.0
2026-05-29
2026-06-02
McMichael Bryan JD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
100000.0—
2026-05-29
2026-06-02
McMichael Bryan JD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
25000.0—
2026-05-29
2026-06-02
McMichael Bryan JD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
15000.0—
2026-05-29
2026-06-02
McMichael Bryan JD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
25000.0—
2026-05-29
2026-06-02
McMichael Bryan JD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
25000.0—
2026-05-29
2026-06-02
McMichael Bryan JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
30000.0—
2026-05-29
2026-06-02
McMichael Bryan JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
100000.0—
2026-05-29
2026-06-02
McMichael Bryan JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
25000.0—
2026-05-29
2026-06-02
McMichael Bryan JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
15000.0—
2026-05-29
2026-06-02
McMichael Bryan JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
25000.0—
2026-05-29
2026-06-02
McMichael Bryan JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
25000.0—
2026-05-29
2026-06-02
McMichael Bryan JD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
30000.0—
2026-05-29
2026-06-02
Lanfear Dennis MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
500000.0—
2026-05-29
2026-06-02
Lanfear Dennis MD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
400000.0—
2026-05-29
2026-06-02
Lanfear Dennis MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
125000.0—
2026-05-29
2026-06-02
Lanfear Dennis MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
402500.0—
2026-05-29
2026-06-02
Lanfear Dennis MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
402500.0—
2026-05-29
2026-06-02
Lanfear Dennis MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
225000.0—
2026-05-29
2026-06-02
Lanfear Dennis MD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
500000.0—
2026-05-29
2026-06-02
Lanfear Dennis MD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
500000.0—
2026-05-29
2026-06-02
Lanfear Dennis MD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
125000.0—
2026-05-29
2026-06-02
Lanfear Dennis MD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
402500.0—
2026-05-29
2026-06-02
Lanfear Dennis MD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
402500.0—
2026-05-29
2026-06-02
Lanfear Dennis MD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
225000.0—
2026-05-29
2026-06-02
Lanfear Dennis MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
200000.0—
2026-05-29
2026-06-02
Lanfear Dennis MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
400000.0—
2026-05-29
2026-06-02
Lanfear Dennis MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
450000.0—
2026-05-29
2026-06-02
Lanfear Dennis MD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
450000.0—
2026-05-29
2026-06-02
Lanfear Dennis MD · Disposition to issuer
Disposed
Stock Option (Right to Buy)
Derivative security
200000.0—
2026-05-29
2026-06-02
Lanfear Dennis MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
500000.0—

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001512762Coherus Oncology, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Coherus BioSciences (United States) · alias · wikidata
  • Coherus BioSciences, Inc. · former SEC name · 2013-01-14 to 2025-05-28
  • BioGenerics, Inc. · former SEC name · 2011-02-23 to 2012-01-03
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$26.39M$28.09M
2023-12-31$257.24M$281.89M
2022-12-31$211.04M$240.76M
2021-12-31$326.55M$402.34M
2020-12-31$475.82M$613.90M
2019-12-31$356.07M$465.04M
2018-12-31$0$0
2017-12-31$1.56M$2.12M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗